Inventor · disambiguated record
Eric Shifrut
Also filed as: SHIFRUT ERIC
6 granted patents·5 pending applications·27 citations·filing 2015–2025
80Inventor score
Top patents by PatentIndex Score
11 records- 0195US11590171B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2022·Granted Feb 28, 2023·2 cites·16 claims
- 0295US11331346B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2021·Granted May 17, 2022·5 cites·18 claims
- 0395US11033584B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2019·Granted Jun 15, 2021·12 cites·31 claims
- 0492US11083753B1Targeted replacement of endogenous T cell receptorsROTH THEODORE LEE·Filed 2021·Granted Aug 10, 2021·8 cites·18 claims
- 0586US2025361287A1Targeted replacement of endogenous t cell receptorsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 0683US12398193B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2023·Granted Aug 26, 2025·0 cites·22 claims
- 0760US2025041338A1Gene targets for t-cell-based immunotherapy to overcome suppressive factorsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0853US12473533B2Gene targets for T-cell-based immunotherapyUNIV CALIFORNIA·Filed 2019·Granted Nov 18, 2025·0 cites·10 claims
- 0952US2021340496A1Compositions and methods for modifying regulatory t cellsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1047US2023066806A1Pooled knock-in screening and heterologous polypeptides co-expressed under the control of endogenous lociUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1133US2017174764A1T-cell receptor cdr3 peptides and antibodiesYEDA RES & DEV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Shifrut files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →